Medical Equipment

Point-Of-Care Molecular Diagnostics Market Forecast 2025–2034: Where Businesses Should Invest Next

November 14, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Predicted Market Size Trajectory For The Point-Of-Care Molecular Diagnostics Market From 2025 To 2034?#_x000D_

The landscape of point-of-care molecular diagnostics has witnessed substantial expansion lately, projected to advance from a valuation of $3.55 billion in 2024 to $3.98 billion just one year later in 2025, reflecting a consistent annual growth rate (CAGR) of 12.0%. Key factors driving this upward trend during the past period include a rising necessity for swift disease identification, the proliferation of infectious disease incidents, the broadening scope of telemedicine applications and decentralized testing, supportive regulatory environments for diagnostics performed at the site of care, and the growing requirement for treatments tailored to individual precision medicine needs._x000D_

_x000D_

Anticipation suggests the market for point-of-care molecular diagnostics is poised for substantial expansion in the ensuing years, with projections indicating it will reach a valuation of $6.92 billion by 2029, reflecting a compound annual growth rate (CAGR) of 14.8%. This upsurge during the projection timeframe owes its momentum to several key factors, such as the continuous reduction in size of diagnostic instruments, the broadening application of POC testing across oncology and hereditary conditions, the tailored development of molecular diagnostics for a variety of uses, the incorporation of artificial intelligence and deep learning methods for interpreting data, and ongoing efforts in monitoring outbreaks of previously unknown infectious diseases. Furthermore, significant shifts shaping this market as foreseen include the adoption of lab-on-a-chip and microfluidic innovations, the convergence of digital health with diagnostics accessible via smartphones, heightened focus on point-of-care solutions for managing COVID-19 and preparing for future pandemics, the rise of diagnostic tools that use AI to forecast outcomes, and the advent of testing platforms based on CRISPR technology._x000D_

_x000D_

#Unlock Your Free Sample Report for Exclusive Market Data:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp_x000D_

_x000D_

#What Are The Key Drivers Of Growth In The Point-Of-Care Molecular Diagnostics Market?#_x000D_

The escalating prevalence of contagious and respiratory ailments is projected to be a major impetus for expansion within the market for point-of-care molecular diagnostics. Illnesses affecting the respiratory tract, brought on by bacterial or viral agents, involve microorganisms impacting breathing functions, and transmission typically occurs through aerosolized droplets from coughing or sneezing, or via direct physical contact; the spectrum of therapeutic interventions for these respiratory conditions ranges from inhaled devices and prescribed oral drugs to intravenous therapies and, crucially, point-of-care molecular diagnostic tools for patient management. Illustratively, official data released by the Office for National Statistics, the recognized national statistical body in the United Kingdom, indicated that for the week concluding December 9, 2022, infection rates in England specifically saw an upward trend among individuals aged 35 to 69, along with a rise observed in the 12 to 24 age cohort; consequently, the heightened incidence of fatal and non-fatal respiratory and infectious diseases acts as a powerful factor fueling the growth trajectory of the point-of-care molecular diagnostics industry._x000D_

_x000D_

#What Are The Leading Segments Analyzed In The Point-Of-Care Molecular Diagnostics Market?#_x000D_

The point-of-care molecular diagnosticsmarket covered in this report is segmented – _x000D_

_x000D_

1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services_x000D_

2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing_x000D_

3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology_x000D_

4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities_x000D_

_x000D_

Subsegments:_x000D_

1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables_x000D_

2) By Instruments And Analyzers: PCR Machines, Microfluidic Devices, Sequencers, Point-of-Care Analyzers_x000D_

3) By Software And Services: Data Management Software, Cloud-Based Solutions, Technical Support And Maintenance Services, Consultation And Training Services_x000D_

_x000D_

#Which Competitive Trends Are Defining The Point-Of-Care Molecular Diagnostics Market Structure?#_x000D_

A significant driver currently influencing the landscape of point-of-care molecular diagnostics is the escalating momentum behind technological advancements. Leading entities within this market are directing their efforts toward delivering solutions that incorporate sophisticated technology, thereby solidifying their competitive standing. These corporations are actively integrating cutting-edge molecular diagnostics at the point of care, including methodologies like ELISA, PCR, mass spectrometry, in situ hybridizations, SK imaging, and DNA microarrays, deploying them in POC instruments engineered to reduce turnaround times and decrease operational expenditures. As a tangible example, in May of 2023, the diagnostic firm Sensible Diagnostics, based in the United States, introduced a PCR system capable of delivering results in just ten minutes, leveraging the diagnostic proficiency accumulated by Curative throughout the pandemic; this PCR platform boasts a ten-minute result window, substantiated by the fact that the company has successfully processed upwards of two million COVID-19 molecular tests at the point of care._x000D_

_x000D_

#Who Are The Key Multinational Companies Dominating The Point-Of-Care Molecular Diagnostics Market?#_x000D_

Major companies operating in the point-of-care molecular diagnostics market include Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMérieux SA, Danaher Corporation, Quidel Corporation, BioMerieux SA, Bio-Rad Laboratories Inc., Sysmex Corporation, Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Biogenex Laboratories Inc., Cepheid Inc., Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Prometheus Laboratories Inc., Ventana Medical Systems Inc., Vermillion Inc., Guardant Health Inc., Exact Sciences Corporation, Biocartis Group NV, ArcherDx Inc., Bio-Techne Corporation, AccuBiotech Co. Ltd., Becton, Dickinson and Company, Chembio Diagnostics Inc., Credo Diagnostics Biomedical Pvt. Ltd., EKF Diagnostics, GenePOC Inc. _x000D_

_x000D_

#Download The Full Report For Exclusive Market Findings:#_x000D_

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report_x000D_

_x000D_

#What Are The Regional Market Dynamics Impacting The Point-Of-Care Molecular Diagnostics Industry?#_x000D_

North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Request A Customized Version Of The Point-Of-Care Molecular Diagnostics Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7046&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Point-Of-Care Molecular Diagnostics Market 2025, By The Business Research Company#_x000D_

_x000D_

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report_x000D_

_x000D_

Molecular Diagnostics Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report_x000D_

_x000D_